Other News To Note
Wednesday, December 15, 2010
Trophos SA, of Marseille, France, said that it received a European Union award of 6 million (US$8 million) to support MitoCare, a two-and-a-half year international, translational medicine project that will begin in January 2011 and will be conducted by a 16-partner consortium led by Trophos. MitoCare will investigate the efficacy and safety of TRO40303 in a Phase II proof-of-concept study to treat cardiac ischemia-reperfusion injury in acute myocardial infarction patients and develop knowledge of biomarkers and models of cardiac ischemia-reperfusion injury, the company said.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.